Authors: Brenin, DR Manasseh, DM El-Tamer, M Troxel, A Schnabel, F Ditkoff, BA Kinne, D

Citation: Dr. Brenin et al., Factors correlating with lymph node metastases in patients with T1 breast cancer, ANN SURG O, 8(5), 2001, pp. 432-437

Authors: Rowe, DH Huang, JZ Kayton, ML Thompson, R Troxel, A O'Toole, KM Yamashiro, D Stolar, CJH Kandel, JJ

Citation: Dh. Rowe et al., Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor, J PED SURG, 35(1), 2000, pp. 30-32

Authors: Moinpour, CM Troxel, A Lovato, LC Eisenberger, M Blumenstein, BA Crawford, ED

Citation: Cm. Moinpour et al., Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial - Response, J NAT CANC, 91(7), 1999, pp. 646-646

Authors: Moinpour, CM Troxel, A Lovato, LC Eisenberger, M Blumenstein, BA Crawford, ED

Citation: Cm. Moinpour et al., Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial - Response, J NAT CANC, 91(4), 1999, pp. 381-382

Authors: Papadopoulos, KP Ayello, J Reiss, RF Troxel, A Kaufman, E Vahdat, LT Antman, KH Hesdorffer, CS

Citation: Kp. Papadopoulos et al., CD34(+) cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer, J HEMATH ST, 8(4), 1999, pp. 357-363

Authors: Papadopoulos, KP Balmaceda, C Fetell, M Kaufman, E Vahdat, LT Bruce, J Sisti, M Isaacson, S De LaPaz, R Savage, DG Troxel, A Antman, KH Hesdorffer, CS

Citation: Kp. Papadopoulos et al., A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors, J NEURO-ONC, 44(2), 1999, pp. 155-162